. "\u056F\u056C\u056B\u0576\u056B\u056F\u0561\u056F\u0561\u0576 \u0583\u0578\u0580\u0571\u0561\u0580\u056F\u0578\u0582\u0574"@hy . . . . "klinisch onderzoek"@nl . . . . . . . "18"^^ . . . . . "Phase 1-2 Study of Low Dose ASTX727 (ASTX727 LD) in Lower Risk MDS"@en . "NCT03502668" . . . . "Phase 1-2 Study of Low Dose ASTX727 (ASTX727 LD) in Lower Risk MDS"@en . . . "Phase 1-2 Study of Low Dose ASTX727 (ASTX727 LD) in Lower Risk MDS"@en . . . . . . . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . . . "2018-07-27T00:00:00Z"^^ . . . . "A Randomized, Open-Label, Phase 1-2 Study of ASTX727 Low Dose (ASTX727 LD) Extended Schedule in Subjects With Lower Risk (IPSS Low or Intermediate-1) Myelodysplastic Syndromes (MDS)"@en . . "122"^^ . "ensayu cl\u00EDnicu"@ast . "2019-06-01T00:00:00Z"^^ . . "clinical trial"@en . .